Introduction
Endothelin-l (ET-1) is a 21 amino acid peptide, first isolated receptor is equisensitive to all ET isopeptides (Sakurai et al., from the culture medium of aortic endothelial cells (Yanag-1990) . ETA and ETB receptors have both been shown to isawa et al., 1988) . ET-1, the related peptides (ET-2 and mediate contractions of various vascular preparations in-ET-3) and the sarafotoxins (SX6a, SX6b, SX6c, SX6d) cause duced by ET/SX peptides (Williams et al., 1991; Bigaud & vasoconstriction, vasodilatation, mitogenesis and various enPelton, 1992; Cristol et al., 1993) . docrine effects (see Rubanyi, 1992) . These effects are mediated
The endothelins are also potent constrictors of airways in by at least two distinct endothelin receptors. The ETA recepvitro and in vivo (see Battistini et al., 1992; Hay et al., 1993) . tor is ET-1-selective (Arai et al., 1990) whereas the ETB In guinea-pigs, these effects appear to be mediated by non-ETA, presumably ETB receptors. For instance, in anaesthetized guinea-pigs, ET-1, ET-2 or ET-3, given intravenously, Author for correspondence.
cause similar bronchoconstrictions (Pons et al., 1991) and in guinea-pig isolated airways, all three isopeptides are equipotent (Maggi et al., 1989a; Cardell et al., 1993) . Similarly, SX6c and IRL 1620, two ETB-selective agonists (Williams et al., 1991; Takai et al., 1992; Watakabe et al., 1992) , cause comparable contractions of guinea-pig bronchi (SX6c; Hay, 1992) and trachea (IRL 1620; Takai et al., 1992) . These data suggest mediation by predominantly ETB receptors. However, others have suggested that ET-1 is more potent than ET-3 in the guinea-pig trachea (Ninomiya et al., 1992) and in the same preparation that SX6c is a much less effective agonist than ET-I (Hay & Luttman, 1992) . Thus, it appears that both ETA and ETB receptors may mediate these contractions. Data from experiments employing endothelin receptor antagonists are similarly contradictory. BQ-123 (Ihara et al., 1992b) or FR 139317 , two selective ETA receptor antagonists, do not affect contractions induced by ET-1 in the isolated bronchus (BQ-123; Hay, 1992) or trachea (FR 139317; Cardell et al., 1993) or bronchoconstriction induced by ET-1 in anaesethetized guinea-pigs (BQ-123; Noguchi et al., 1993) , suggesting mediation by ETB receptors. Conversely, BQ-123 partially inhibits the contractions induced by ET-1 in the guinea-pig trachea (Hay, 1992) , suggesting an involvement of ETA receptors. Similarly, BQ-123 also inhibits 40% of the contraction induced by ET-1 in the rat trachea (Henry, 1993) . These conflicting reports are indicative of the fact that the receptors mediating the effects of the ET/SX peptides in the guinea-pig airways have not been systematically characterized. Here, using as agonists ET-1 and IRL 1620 and as antagonists, BQ-123 or FR139317 (ETA receptor selective) or PD 145065 (ETA/ETB receptor nonselective; Cody et al., 1993) , we have characterized further the receptors mediating the contractile effects of the endothelins in the guinea-pig trachea (with or without epithelium), upper bronchus and lung parenchyma.
Methods

Tissue preparation
Male Hartley guinea-pigs weighing 350-450 g were killed by cervical dislocation and rapidly bled. The trachea, upper bronchus and lung parenchyma were excised, placed in Krebs-Henseleit buffer (composition in mM: NaCl 118, KCI 4.7, CaCl2 2.5, KH2PO4 1.18, NaHCO3 25, MgSO4.7H20 1.18 and glucose 5.6, pH 7.4) and trimmed of connective tissue and fat. The trachea and upper bronchus were cut into spirals. Some tracheal preparations were denuded of their epithelium by gentle rubbing with a wet cotton swab. Strips of peripheral parenchyma were prepared from the anterior surface of the lower lobe. The tissues were mounted in 10 ml organ baths and connected to auxotonic force-displacement transducers (Harvard Bioscience Apparatus) under tensions of 1.5 g. Tissues were allowed to stabilize for 1 h in warmed (37°C) and gassed (95% 02:5% CO2) Krebs-Henseleit solution with washing every 15 min. Changes in length were recorded continuously on a Linearcorder (Graphtec, model WR 3300, Japan).
Experimental protocol
Following an equilibration period (60 min) tissues were contracted three times with histamine (5 x 10-6 M) to induce 80% of the maximal contraction, with a 30 min washout period between contractions. Tissues were then incubated (20-30 min) with or without indomethacin (10-5 M), BQ-123 (10-6, 10-5M), FR139317 (10-6, 1-5M), PD 145065 (10-6, l0o-, 10-4 M) or vehicle before addition of cumulative concentrations of ET-1 (10-9 to 3 x 10-7M) or IRL 1620 (10`0 to 10-6 M). Each preparation was used for only one concentration-response curve for ET-l or IRL 1620. Responses are expressed as a percentage of the contraction evoked by 5 x 10-6 M histamine.
Drugs
Endothelin-1 (ET-1) and IRL 1620 (Suc-[Glu9, Ala""5] ET-l (8-21)) were synthesized at the INRS-Sante (Montreal, P.Q., Canada). IRL 1620 was also obtained as a gift from the International Research Laboratories, CIBA-GEIGY (Takarazuka, Japan). ET-i and IRL 1620 were dissolved in distilled water and stored in aliquots of 5 x 10-5 M at -200C. Indomethacin (Sigma Chemicals Co., Poole, Dorset) was freshly dissolved each day in 5% w/v NaHCO3. 
]cycloheptene-10,1 1-dihydroglycine) were dissolved in distilled water and stored in aliquots of 10-M at -20°C. All drugs were further diluted with Krebs-Henseleit solution when necessary. Histamine dihydrochloride was obtained from Sigma Chemical Co. (Poole, Dorset).
Statistical analysis
All values are expressed as mean ± s.e.mean. Statistical analysis of the data was performed by an unpaired, twotailed, Mann-Whitney U test and P<0.05 was considered significant.
Results
Endothelin-J verus IRL 1620
Endothelin-l or IRL 1620 caused strong concentrationdependent contractions of the four guinea-pig airway preparations (Table 1 Figure 2b ).
In the trachea with epithelium, PD 145065 antagonized contractions to ET-1 causing a shift to the right in the concentration-response curve of 7 fold (10-5 M) and 60 fold (10-4 M) (Table 1; Figure 2d ) without causing any reduction in the responses at 3 x 0-7M. BQ-123 (10-s M) had no effect, whereas FR139317 (10-s M) caused a significant inhibition (31%) of the contraction induced by 3 x 10-M ET-1, and shifted the ET-1 concentration-response curve to the right by 8 fold (Figure 2c ). between tracheal strips ± epithelium. tP< 0.05 between ET-l and IRL 1620 (compared by an unpaired, two-tailed, Mann-Whitney U test).
FR139317 (10-iM) produced a smaller inhibition (2 fold), especially at higher concentrations of ET-1 (>3 x 10-8 M).
PD 145065 (10-6 M and I0-5 M) caused shifts of 3 and > 50
fold in the concentration-response curve to ET-1. PD 145065 (10-6 M) did not affect the contractions induced by 3 x 10-7 M ET-1, while PD 145065 (10-5 M) caused a 62% inhibition (Table 1 Effect of antagonists on responses of the guinea-pig trachea to IRL 1620
IRL 1620 caused only contractions of the trachea which were significantly inhibited by BQ-123 (10-5 M) or FR139317 (10-5M) ( Table 1 ; Figure 3a ). For instance, the two antagonists attenuated contractions to 3 x 10-7M IRL 1620 by 48% and 59%, respectively. PD 145065 (10-6 M) and (10-5 M)
shifted the concentration-response curve for IRL 1620 to the right by 7 and >22 fold, respectively, and reduced the response to 3 x 10-M IRL 1620 by 52% and 79%, respectively (Table 1 ; Figure 3b ). In the trachea without epithelium, the concentrationresponse curve to IRL 1620, which was potentiated by the removal of the epithelium, was shifted to the right by more than 100 fold by PD 145065 (10-6 and 10-5 M) ( Table 1 ; Figure 3d ). The responses to 3 x 10-7M IRL 1620 were attenuated by 73% and 77%, respectively, by the same concentrations of PD 145065 (Table 1 ; Figure 3d ). (10-6 M) or FR139317 (10-6 M) had no effect. Either antagonist at 10-5 M caused a significant inhibition with FR139317 being more effective (Table 1 ; Figure 3c ). Effect of antagonists on responses of the guinea-pig lung parenchyma to ET-1
In the guinea-pig lung parenchyma, BQ-123 (10-5 M) shifted the concentration-curve for ET-1 by 5 fold to the right (Table 1 ; Figure 2g ) as did indomethacin (10-SM; n = 9; EC50: 54.9 ± 14.0 nM (5 fold to the right); response at 3 x 10-7 M: 49.2 ± 3.2%; Figure 2g ). Figure 3h ). BQ-123 (10-6 M to 10-5 M) or FR139317 (10-6 M) did not affect responses to concentrations of IRL 1620 greater than 10-8M (Table 1 ; Figure 3g ). For instance, FR139317 (10-M) caused a 7 fop..
shift to the right of the IRL 1620 concentration-response curve, but no inhibition of the response at 3 x I0-M (Table   1 ; Figure 3g ).
BQ-123, FR139317 or PD 145065 (up to 10-4 M) had no effect on the basal tension of the tissues or on the responses of any of the four preparations to histamine.
Discussion
The present study demonstrates that contractile responses to ET-1 and IRL 1620 in guinea-pig isolated airways are mediated almost exclusively by ETB receptors. PD 145065, an ETA/ This amplifies and agrees with data from experiments using both bronchial (Hay, 1992) and tracheal (Cardell et al., 1993) preparations in vitro, and from studies examining the responses of guinea-pig airways in vivo (Noguchi et al., 1993 ).
In our study, all three antagonists (at 1O' M) abolished the transient relaxations of the trachea induced by low concentrations (<10-8 M) of ET-1. At the same time, our results show that BQ-123 or FR139317 (10-5 M) slightly potentiated contractions to low concentrations of ET-l (< 3 x 10-7 M) without affecting those to higher concentrations of ET-1. These transient relaxations (as reported by Turner et al., 1989; White et al., 1991) are mediated via ETA receptors, and counteract the direct constrictor effect of the endothelins. The receptors mediating this effect are most probably situated on the epithelial cells, for transient relaxations were not seen in preparations without epithelium. Furthermore, removal of the epithelium of the trachea potentiated the contractile effects of ET-1. The relaxation may well be secondary to an increase in production of prostaglandin E2 (PGE2), the predominant airway product of arachidonic acid in epithelial cells, which relaxes airway smooth muscle (Goodwin, 1989) and is released from feline tracheal epithelial cells by ET-l (Wu et al., 1993) . In intact tracheal strips, IRL 1620 induced similar contractions to ET-l suggesting ETB receptors mediate this response.
Contractions induced by IRL 1620 were strongly inhibited or abolished by PD 145065. Similarly, the higher concentration of PD 145065 (10-5 M) slightly reduced the contractions to ET-1 at > 10-7 M. The greater effectiveness of PD 145065 against IRL 1620 is not explained by the lower binding affinity of this selective agonist compared to ET-1, for competitive binding assays revealed almost identical displacement curves (Watakabe et al., 1992) . However, IRL 1620 binds to endothelin receptors in a reversible manner, whereas only dissociates very slowly from the binding sites (Watakabe et al., 1992) . This different sensitivity of agonists to antagonists would agree with our previous observations that PD 142893, PD 145065 and Ro 46-2005 46- (Clozel et al., 1993 , which are all ETA/ETB non-selective receptor antagonists, more actively antagonize responses to SX6c or IRL 1620 than ET-1 at ETB receptors (Warner et al., 1993a,b; unpublished observations) . This is of great interest for it suggests that the relative effectiveness of endothelin receptor antagonists varies with the agonist used. It also implies that great care should be taken in assessing the potency of endothelin receptor antagonists by competition experiments employing synthetic ligands.
Neither FR139317 (10-6M) nor BQ-123 (10-6M) had any significant effect on the contractions induced by IRL 1620. However, a concentration of 10-M of either ETA-antagonist caused a significant inhibition of contractions induced by IRL 1620, shifting the IRL 1620 concentration-response curve to a similar extent to PD 145065 (10-6 M). Similarly, high concentrations of BQ-123 inhibit ET-1-induced bronchoconstriction in vivo (Noguchi et al., 1993) . Possibly this is because at these high concentrations (10-M), BQ-123 or FR139317 can displace ET-1 binding to ETB receptors. In- (Ihara et al., 1992; Sogabe et al., 1993; Aramori et al., 1993) . Removal of the epithelium in the trachea potentiated the contractile effects of both ET-1 (as shown by Maggi et al., 1989b; Hay, 1989; 1990) and IRL 1620 (this study), as has been shown for other bronchoconstrictor agents such as histamine, acetylcholine, 5-hydroxytryptamine and leukotriene C4 and D4 (Barnes et al., 1985; Holroyde, 1986; Goldie et al., 1986; Hay et al., 1987) . Interestingly, while ET-1 and IRL 1620 were equipotent in contracting the intact trachea, ET-1 was three times more potent than IRL 1620 in contracting tracheal preparations without epithelium. This may be explained by the additional loss of the ET-1-induced relaxant response, which is epithelium-dependent (see above). In the trachea without epithelium, BQ-123 (10-5M) had no effect on contractions induced by ET-1 while FR139317 (10-M) significantly inhibited them. This suggests that the trachea contains a mixed population of endothelin receptors. This would agree with previous reports comparing both agonist potencies and the effects of the endothelin receptor antagonists (Maggi et al., 1989b; Ninomiya et al., 1992; Hay & Luttman, 1992; Henry, 1993) .
In the upper bronchus, ET-1 and IRL 1620 produced superimposable concentration-response curves suggesting mediation by a homogeneous ETB receptor population. BQ-123 or FR139317 were ineffective against ET-1 but PD 145065 antagonized the effects of ET-1 or IRL 1620. As before, high concentrations of BQ-123 or FR139317 inhibited contractions induced by IRL 1620.
The present study supports the suggestion (Filep et al., 1991) that the contractions induced by ET-1 in the lung parenchyma are partly mediated through the release of eicosanoids, particularly thromboxane A2. BQ-123 may block the release of TxA2 for it significantly inhibited part of the response curve induced by ET-1 and this inhibition was not additive to that of indomethacin. This agrees with experiments using rat perfused lungs where BQ-123 blocks the release of prostacyclin and/or thromboxane A2 induced by ET-1 (D'Orleans-Juste et al., 1992) . It also provides a role for ETA receptors, which account for 15% of ET-1 binding in the guinea-pig lung (Ihara et al., 1992a) .
Thus, our data indicate that ET-l activates ETA receptors on tracheal airway epithelial cells and cells in the lung parenchyma of the guinea-pig to induce the release of prostanoids. In the trachea, this causes a transient relaxation and in the lung parenchyma, contraction through the release of thromboxane A2 (TxA2). More importantly > 85% of the contractions induced by ET-1 in guinea-pig airways are mediated via ETB receptors most probably present on the airway smooth muscle. As ET-1 may be an endogenous regulator of airway tone and is secreted from tracheal and bronchial epithelial cells (Black et al., 1989; Mattoli et al., 1990) , endothelins may play an active role in diseases such as asthma, bronchitis and adult respiratory distress syndrome. These airway diseases are associated with vascular remodelling, reduction of airway calibre, increased microvascular permeability, ciliary function, ion transport and mucin release which are all affected by the endothelins (Wu et al., 1990; Tamaoki et al., 1991; Plews et al., 1991; Peacock et al., 1992; Helset et al., 1993) . The ability of PD 145065 to antagonize ET-1 in airway tissues therefore suggests it may be beneficial in disease states. 
